The collaboration agreement with Regeneron to develop and commercialize fully-human therapeutic antibodies was presented by Mr. Jean-Claude Muller, Senior Vice President Administration and Resources, and Mr. Jean-Michel Lévy, Senior Vice President Business Development. The presentation was followed by a Q&A session.
Recorded audio webcast held on November 29 at 12 noon (CET)